Yang Gao1, Shubin Li2, Xijing Zhuang3, Feng Gao3, Lei Shi3, Xu Meng1. 1. Department of Cardiology Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. 2. Department of Cardiology Surgery, Xinxiang Central Hospital, Xinxiang, China. 3. Department of Cardiology Surgery, Dalian Municipal Central Hospital, Dalian, China.
Abstract
BACKGROUND: Function tricuspid regurgitation (TR) is frequently observed in patients undergoing mitral valve surgery. It is unclear that mitral valve repair (MVr) or mitral valve replacement (MVR) has influence on the likelihood of late TR progression. METHODS: This study included 193 patients with degenerative mitral valve disease who underwent either MVr or MVR. Detailed preoperative materials, follow-up information, and echocardiographic data were collected and statistically analyzed. RESULTS: At 6 and 12 months postoperatively, MVR patients were more likely to have New York Heart Association (NYHA) class III or IV symptoms than MVr patients (6 mo: 15.2% vs 5.0%, 12 mo: 13.0% vs 4.0%, both P <0.05). At 24 months, the incidence of Grade 1+ TR was significantly higher in MVR patients than MVr patients (25.0% vs 12.9%, P <0.05). In univariate analysis, age (odds ratio [OR] = 1.036, P = 0.036), MVR (OR = 2.256, P = 0.033), and preoperative TR area (TRA; OR = 1.541, P = 0.047) were significant predictors for TR progression. In multivariate logistics analysis, only MVR was independently risk factor (P = 0.006). Subsequently, patients were divided into tricuspid valve repair (TVr) group and untreated group. In both subgroups, MVR patients were associated with significantly larger TRA (P <0.01). CONCLUSION: MVR was an independent risk factor for TR progression, whether tricuspid valve was treated or not.
BACKGROUND:Function tricuspid regurgitation (TR) is frequently observed in patients undergoing mitral valve surgery. It is unclear that mitral valve repair (MVr) or mitral valve replacement (MVR) has influence on the likelihood of late TR progression. METHODS: This study included 193 patients with degenerative mitral valve disease who underwent either MVr or MVR. Detailed preoperative materials, follow-up information, and echocardiographic data were collected and statistically analyzed. RESULTS: At 6 and 12 months postoperatively, MVR patients were more likely to have New York Heart Association (NYHA) class III or IV symptoms than MVr patients (6 mo: 15.2% vs 5.0%, 12 mo: 13.0% vs 4.0%, both P <0.05). At 24 months, the incidence of Grade 1+ TR was significantly higher in MVR patients than MVr patients (25.0% vs 12.9%, P <0.05). In univariate analysis, age (odds ratio [OR] = 1.036, P = 0.036), MVR (OR = 2.256, P = 0.033), and preoperative TR area (TRA; OR = 1.541, P = 0.047) were significant predictors for TR progression. In multivariate logistics analysis, only MVR was independently risk factor (P = 0.006). Subsequently, patients were divided into tricuspid valve repair (TVr) group and untreated group. In both subgroups, MVR patients were associated with significantly larger TRA (P <0.01). CONCLUSION: MVR was an independent risk factor for TR progression, whether tricuspid valve was treated or not.
Authors: Siham Lazam; Jean-Louis Vanoverschelde; Christophe Tribouilloy; Francesco Grigioni; Rakesh M Suri; Jean-Francois Avierinos; Christophe de Meester; Andrea Barbieri; Dan Rusinaru; Antonio Russo; Agnès Pasquet; Hector I Michelena; Marianne Huebner; Joseph Maalouf; Marie-Annick Clavel; Catherine Szymanski; Maurice Enriquez-Sarano Journal: Circulation Date: 2016-11-29 Impact factor: 29.690
Authors: Mario Sénéchal; Jimmy MacHaalany; Olivier F Bertrand; Kim O'Connor; Julie Parenteau; Isaïe-Nicolas Dubois-Sénéchal; Olivier Costerousse; Michelle Dubois; Pierre Voisine Journal: Am J Cardiol Date: 2013-05-16 Impact factor: 2.778
Authors: A Marc Gillinov; Eugene H Blackstone; Edward R Nowicki; Worawong Slisatkorn; Ghannam Al-Dossari; Douglas R Johnston; Kristopher M George; Penny L Houghtaling; Brian Griffin; Joseph F Sabik; Lars G Svensson Journal: J Thorac Cardiovasc Surg Date: 2008-03-04 Impact factor: 5.209